Committee for Pharmaceutical Policy
The Committee for Pharmaceutical Policy and Advocacy is a new committee of the K.N.P.S.V., established in 2022. The committee focuses on representing the interests of students whose study association is a department of the K.N.P.S.V. General interest representation includes two related categories: interest representation and policy. Interest representation involves representing the interests of students during and after their studies within the K.N.P.S.V. Examples include improving education, good pharmacy practice, and good working conditions. The “policy” category includes addressing issues. These issues may relate to education, education in other countries, or sustainability (e.g., pharmaceutical waste). Mental health, the pharmaceutical industry in the Netherlands compared to other countries, or antibiotic resistance can also be subjects of such issues.
The Committee for Pharmaceutical Policy and Advocacy collaborates with third parties, including professional associations such as the KNMP, NIA, NVZA, NVKFB, and VJA. They also collaborate with EPSA and IPSF.
This year, the Committee for Pharmaceutical Policy and Advocacy organized the Bachelor Activity and the theme week, both of which focused on AMR: Antimicrobial Resistance.
Additionally, we also have two board members who sit on our committee, namely Lieke van Megen and Anton Klaassen Through Lieke, we can represent the interests of Dutch (bio)pharmacy students at the international level (IPSF), and through Anton at the European level (EPSA).